meta-analysis | Q815382 |
scholarly article | Q13442814 |
P50 | author | Igor Rudan | Q28050008 |
Daniel Feikin | Q5217119 | ||
Eva Harris | Q5415063 | ||
Anna Roca | Q103000144 | ||
Wences Arvelo | Q106466500 | ||
Eric A F Simões | Q109845655 | ||
Marilla G. Lucero | Q109866601 | ||
Shobha Broor | Q114312825 | ||
W Abdullah Brooks | Q114401281 | ||
Stephen R C Howie | Q114401282 | ||
Phyllis Carosone-Link | Q114401283 | ||
Doli Goswami | Q114401284 | ||
Niranjan Bhat | Q114415243 | ||
Malinee Chittaganpitch | Q114574778 | ||
Maurice Ope | Q114574975 | ||
Erica Dueger | Q116997037 | ||
Angel Balmaseda | Q28484000 | ||
Evropi Theodoratou | Q30438198 | ||
Thomas Briese | Q32640523 | ||
Philippe Buchy | Q32654119 | ||
Anand Krishnan | Q38321437 | ||
Marc-Alain Widdowson | Q38848822 | ||
Marietjie Venter | Q39062606 | ||
Aubree Gordon | Q47502970 | ||
James Berkley | Q47503663 | ||
Shabir A. Madhi | Q56065756 | ||
Cristina O'Callaghan-Gordo | Q56450772 | ||
Robert F Breiman | Q60502430 | ||
Harish Nair | Q61081121 | ||
Harry Campbell | Q74299327 | ||
Keith P. Klugman | Q79427702 | ||
Sirenda Vong | Q87373879 | ||
Anthony W Mounts | Q88494993 | ||
Kim A Lindblade | Q88599285 | ||
Rafal Tokarz | Q90460141 | ||
Mark A Katz | Q91141643 | ||
Sonja J Olsen | Q91539589 | ||
Bradford D Gessner | Q92164469 | ||
P2093 | author name string | Laurie Kamimoto | |
Peter F Wright | |||
Masatoki Sato | |||
Osaretin Chimah | |||
Masahiko Katayose | |||
James Mark Simmerman | |||
Valerie Evans | |||
Bharti Gaur | |||
Walter Ochieng | |||
P2860 | cites work | Epidemiology and etiology of childhood pneumonia | Q22241278 |
Meta-analysis in clinical trials | Q27860779 | ||
Burden of disease caused by Streptococcus pneumoniae in children younger than 5 years: global estimates | Q28258300 | ||
Global, regional, and national causes of child mortality in 2008: a systematic analysis | Q28282386 | ||
Mortality associated with influenza and respiratory syncytial virus in the United States | Q29615578 | ||
Influenza-associated hospitalizations in the United States | Q29619463 | ||
Global burden of acute lower respiratory infections due to respiratory syncytial virus in young children: a systematic review and meta-analysis | Q29619821 | ||
Pneumococcal pneumonia and influenza: a deadly combination | Q30227641 | ||
Insights into the interaction between influenza virus and pneumococcus | Q30355570 | ||
The burden of influenza in East and South-East Asia: a review of the English language literature | Q30377234 | ||
Strategy to enhance influenza surveillance worldwide. | Q30380636 | ||
Acute respiratory illness incidence and death among children under two years of age on Lombok Island, Indonesia. | Q31097550 | ||
A prospective three-year cohort study of the epidemiology and virology of acute respiratory infections of children in rural India | Q33286812 | ||
Fatal cases of influenza a in childhood | Q33513974 | ||
The epidemiology of hospitalized influenza in children, a two year population-based study in the People's Republic of China | Q33547664 | ||
Multiplex PCR for Typing and Subtyping Influenza and Respiratory Syncytial Viruses | Q33679059 | ||
Viral etiology of severe pneumonia among Kenyan infants and children. | Q34262582 | ||
Burden of disease caused by Haemophilus influenzae type b in children younger than 5 years: global estimates | Q35002443 | ||
Clinical evaluation of the SD Bioline influenza virus antigen test for rapid detection of influenza viruses A and B in children and adults during the influenza season | Q36097119 | ||
Incidence of influenza and associated illness in children aged 0-19 years: a systematic review | Q36264226 | ||
Estimating influenza hospitalizations among children | Q36403778 | ||
Respiratory syncytial virus infection and disease in infants and young children observed from birth in Kilifi District, Kenya | Q36606787 | ||
Incidence, complications, and risk factors for prolonged stay in children hospitalized with community-acquired influenza | Q36778355 | ||
The burden of influenza in children | Q36807323 | ||
Incidence and severity of respiratory syncytial virus pneumonia in rural Kenyan children identified through hospital surveillance | Q37388667 | ||
Seasonal patterns of viral and bacterial infections among children hospitalized with community-acquired pneumonia in a tropical region | Q37852749 | ||
The epidemiology of acute respiratory infections in children and adults: a global perspective | Q38031952 | ||
The etiology of pneumonia in malnourished and well-nourished Gambian children | Q38860327 | ||
Influenza is a major contributor to childhood pneumonia in a tropical developing country | Q38922422 | ||
Clinical features of Malaysian children hospitalized with community-acquired seasonal influenza. | Q39426274 | ||
Viral pathogens associated with acute respiratory infections in central vietnamese children | Q39617255 | ||
Influenza and other respiratory virus-related emergency department visits among young children | Q39761105 | ||
Etiologic agents and outcome determinants of community-acquired pneumonia in urban children: a hospital-based study | Q39846573 | ||
Seasonal pattern of pneumonia mortality among under-five children in Nairobi's informal settlements | Q39905419 | ||
Influenza enhances susceptibility to natural acquisition of and disease due to Streptococcus pneumoniae in ferrets. | Q40101888 | ||
Influenza A and respiratory syncytial virus hospital burden in young children in East London | Q40169142 | ||
Comparison of human metapneumovirus, respiratory syncytial virus and influenza A virus lower respiratory tract infections in hospitalized young children | Q40299246 | ||
Health-seeking patterns among participants of population-based morbidity surveillance in rural western Kenya: implications for calculating disease rates | Q40350088 | ||
Influenza-related hospitalisations in children | Q40376140 | ||
Effectiveness of maternal influenza immunization in mothers and infants | Q40409398 | ||
Accuracy and interpretation of rapid influenza tests in children. | Q40460925 | ||
Estimating the undetected burden of influenza hospitalizations in children. | Q40462801 | ||
Surveillance for influenza admissions among children hospitalized in Canadian immunization monitoring program active centers, 2003-2004. | Q40470797 | ||
The underrecognized burden of influenza in young children. | Q40475111 | ||
Influenza-related hospitalizations in children younger than three years of age. | Q40475797 | ||
Influenza and the rates of hospitalization for respiratory disease among infants and young children | Q41716369 | ||
Virologically confirmed population-based burden of hospitalization caused by influenza A and B among children in Hong Kong. | Q43174741 | ||
Viral etiology of pneumonia in a cohort of newborns till 24 months of age in Rural Mirzapur, Bangladesh | Q43176736 | ||
Viral respiratory infections in hospitalized and community control children in Alaska | Q43439849 | ||
Role of respiratory viruses in acute upper and lower respiratory tract illness in the first year of life: a birth cohort study | Q43449612 | ||
National disease burden of respiratory viruses detected in children by polymerase chain reaction | Q43596844 | ||
Influenza-related hospitalisations among children aged less than 5 years old in the Basque Country, Spain: a 3-year study (July 2001-June 2004). | Q43614574 | ||
The descriptive epidemiology of severe lower respiratory tract infections in children in Kiel, Germany | Q43617102 | ||
Rates of hospitalisation for influenza, respiratory syncytial virus and human metapneumovirus among infants and young children | Q43626562 | ||
Burden of seasonal influenza hospitalization in children, United States, 2003 to 2008. | Q43695395 | ||
Severe pneumococcal pneumonia in previously healthy children: the role of preceding influenza infection | Q43812278 | ||
Human metapneumovirus: a new player among respiratory viruses | Q45051015 | ||
Etiology and epidemiology of viral pneumonia among hospitalized children in rural Mozambique: a malaria endemic area with high prevalence of human immunodeficiency virus | Q45373360 | ||
Seasonality, incidence, and repeat human metapneumovirus lower respiratory tract infections in an area with a high prevalence of human immunodeficiency virus type-1 infection | Q45400150 | ||
New point of care test is highly specific but less sensitive for influenza virus A and B in children and adults | Q45613161 | ||
Population-based surveillance for hospitalizations associated with respiratory syncytial virus, influenza virus, and parainfluenza viruses among young children | Q45632080 | ||
Respiratory viruses in the pediatric intensive care unit: prevalence and clinical aspects. | Q47834572 | ||
Burden of influenza in children in the community | Q47924586 | ||
Prospective population-based study of viral lower respiratory tract infections in children under 3 years of age (the PRI.DE study). | Q47925908 | ||
Burden of interpandemic influenza in children younger than 5 years: a 25-year prospective study | Q50690322 | ||
Multistate Surveillance for Laboratory-Confirmed, Influenza-Associated Hospitalizations in Children | Q57385008 | ||
Epidemiology, Complications, and Cost of Hospitalization in Children With Laboratory-Confirmed Influenza Infection | Q59201123 | ||
Etiology of acute respiratory tract infections among children in a combined community and hospital study in Rio de Janeiro | Q72344382 | ||
Pneumococcal capsular antigen detection after enrichment culture: an alternative to culture methods in epidemiologic research | Q73176709 | ||
Impact of respiratory infections by influenza viruses A and B in pediatrics patients from Federal University of Paraná, Brazil | Q80599974 | ||
Human metapneumovirus infection in young children hospitalized with respiratory tract disease | Q82986867 | ||
P433 | issue | 9807 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | meta-analysis | Q815382 |
systematic review | Q1504425 | ||
P304 | page(s) | 1917-1930 | |
P577 | publication date | 2011-11-10 | |
P1433 | published in | The Lancet | Q939416 |
P1476 | title | Global burden of respiratory infections due to seasonal influenza in young children: a systematic review and meta-analysis | |
P478 | volume | 378 |
Q37130821 | A comprehensive review of the epidemiology and disease burden of Influenza B in 9 European countries |
Q38576205 | A global perspective of maternal influenza immunization |
Q33681189 | A joint analysis of influenza-associated hospitalizations and mortality in Hong Kong, 1998-2013. |
Q31107055 | A nice day for an infection? Weather conditions and social contact patterns relevant to influenza transmission |
Q34291070 | A phase 1, open-label safety and immunogenicity study of an AS03-adjuvanted trivalent inactivated influenza vaccine in children aged 6 to 35 months. |
Q30427988 | A prospective study of agents associated with acute respiratory infection among young American Indian children |
Q50760715 | A prospective study to assess the burden of influenza-related hospitalizations and emergency department visits among children in Bilbao, Spain (2010-2011) |
Q91912779 | A prospective study to assess the burden of influenza-related hospitalizations and emergency department visits among children in Bilbao, Spain (2010-2011) |
Q47601372 | A retrospective observational analysis of post-pandemic influenza-related outcomes in the United Kingdom, 2010-2014. |
Q38258646 | A review of neuraminidase inhibitor susceptibility in influenza strains |
Q89530685 | A severe influenza season in Austria and its impact on the paediatric population: mortality and hospital admission rates, november 2017 - march 2018 |
Q30381717 | A systematic review of the social and economic burden of influenza in low- and middle-income countries. |
Q54626497 | A trivalent, inactivated influenza vaccine (Vaxigrip®): summary of almost 50 years of experience and more than 1.8 billion doses distributed in over 120 countries |
Q42284304 | A “pre-seasonal” hospital outbreak of influenza pneumonia caused by the drift variant A/Victoria/361/2011-like H3N2 viruses, Hong Kong, 2011 |
Q37498000 | AAV Vectors Vaccines Against Infectious Diseases. |
Q47658890 | AS03- and MF59-Adjuvanted Influenza Vaccines in Children |
Q52684550 | Acceptability of intranasal live attenuated influenza vaccine, influenza knowledge and vaccine intent in The Gambia |
Q37606436 | Activation of IL-27 signalling promotes development of postinfluenza pneumococcal pneumonia |
Q96132922 | Active SMS-based surveillance of adverse events following immunisation with influenza and pertussis-containing vaccines in Australian pregnant women using AusVaxSafety |
Q35871995 | Acute Febrile Illness and Influenza Disease Burden in a Rural Cohort Dedicated to Malaria in Senegal, 2012-2013. |
Q34595933 | Acute lower respiratory infections in ≥ 5 year -old hospitalized patients in Cambodia, a low-income tropical country: clinical characteristics and pathogenic etiology |
Q40082914 | Advances in Vaccines to Prevent Viral Respiratory Illnesses in Children |
Q49822493 | Advances in measuring influenza burden of disease |
Q30401077 | Advancing new vaccines against pandemic influenza in low-resource countries. |
Q64099604 | Aetiology and risks factors associated with the fatal outcomes of childhood pneumonia among hospitalised children in the Philippines from 2008 to 2016: a case series study |
Q30424161 | Aflunov®: a vaccine tailored for pre-pandemic and pandemic approaches against influenza |
Q30429613 | Afriflu2—Second international workshop on influenza vaccination in the African continent—8 November 2012, Cape Town (South Africa) |
Q30359375 | An evaluation of the emerging vaccines against influenza in children. |
Q64136841 | An outbreak investigation of paediatric severe acute respiratory infections requiring admission to intensive care units - Fiji, May 2016 |
Q90798646 | Analysis of influenza virus-induced perturbation in autophagic flux and its modulation during Vitamin D3 mediated anti-apoptotic signaling |
Q47567038 | Announcing the publication of the WHO immunological basis for immunization series module on influenza vaccines. |
Q93136666 | Antigen specific vaccine hesitancy in pregnancy |
Q38401883 | Antiviral treatment of influenza in South Korea |
Q28260818 | Antivirals for treatment of influenza: a systematic review and meta-analysis of observational studies |
Q36120877 | Assembling GHERG: Could "academic crowd-sourcing" address gaps in global health estimates? |
Q82479986 | Assessment of the burden of influenza in children |
Q92599691 | Assessment of two complementary influenza surveillance systems: sentinel primary care influenza-like illness versus severe hospitalized laboratory-confirmed influenza using the moving epidemic method |
Q41922709 | Association between Haemagglutination inhibiting antibodies and protection against clade 6B viruses in 2013 and 2015. |
Q57153713 | Attitudes and barriers associated with seasonal influenza vaccination uptake among public health students; a cross-sectional study |
Q33908117 | Attributable Fraction of Influenza Virus Detection to Mild and Severe Respiratory Illnesses in HIV-Infected and HIV-Uninfected Patients, South Africa, 2012-2016. |
Q90187064 | Baloxavir marboxil in Japanese pediatric patients with influenza: safety and clinical and virologic outcomes |
Q26749036 | Best practice in the prevention and management of paediatric respiratory syncytial virus infection |
Q38406507 | Breastfeeding and adolescent blood pressure: evidence from Hong Kong's "Children of 1997" Birth Cohort. |
Q33649040 | Broad protection against influenza infection by vectored immunoprophylaxis in mice |
Q98161899 | Broader neutralization of CT-P27 against influenza A subtypes by combining two human monoclonal antibodies |
Q58493922 | Burden and Epidemiology of Influenza- and Respiratory Syncytial Virus-Associated Severe Acute Respiratory Illness Hospitalization in Madagascar, 2011-2016 |
Q89763245 | Burden and seasonality of medically attended influenza like illness (ILI) in Ethiopia, 2012 to 2017 |
Q36458508 | Burden of Influenza and Influenza-associated Pneumonia in the First Year of Life in a Prospective Cohort Study in Managua, Nicaragua |
Q41919077 | Burden of Influenza in 4 Ecologically Distinct Regions of Peru: Household Active Surveillance of a Community Cohort, 2009-2015. |
Q53692287 | Burden of Influenza in Less Than 5-Year-Old Children Admitted to Hospital with Pneumonia in Developing and Emerging Countries: A Descriptive, Multicenter Study |
Q41921632 | Burden of influenza among hospitalized febrile children in Ghana |
Q94562828 | Burden of influenza-associated respiratory and circulatory mortality in India, 2010-2013 |
Q64230038 | Burden of medically attended influenza in Norway 2008-2017 |
Q39393694 | Burden of respiratory syncytial virus infection in young children |
Q57477799 | Burden of seasonal influenza in sub-Saharan Africa: a systematic review protocol |
Q64245361 | Burden, effectiveness and safety of influenza vaccines in elderly, paediatric and pregnant populations |
Q40112217 | C-Reactive Protein Mediating Immunopathological Lesions: A Potential Treatment Option for Severe Influenza A Diseases |
Q57094380 | CD4 T cells in protection from influenza virus: Viral antigen specificity and functional potential |
Q85498591 | Challenges of Establishing Routine Influenza Sentinel Surveillance in Ethiopia, 2008-2010 |
Q34568223 | Challenges to Evaluating Respiratory Syncytial Virus Mortality in Bangladesh, 2004–2008 |
Q30365041 | Challenges to global pandemic mortality estimation. |
Q38937934 | Changing social contact patterns under tropical weather conditions relevant for the spread of infectious diseases |
Q30400386 | Characteristics of seasonal influenza A and B in Latin America: Influenza surveillance data from ten countries |
Q96953583 | Characterization and Evolutionary Analysis of a Novel H3N2 Influenza A Virus Glycosylation Motif in Southern China |
Q53629636 | Child pneumonia at a time of epidemiological transition |
Q30368689 | Children hospitalised with influenza-associated pneumonia during the 2009 pandemic displayed increased disease severity. |
Q42263163 | Children with multiple viral respiratory infections are older than those with single viruses |
Q47643212 | Children's Oxygen Administration Strategies Trial (COAST): A randomised controlled trial of high flow versus oxygen versus control in African children with severe pneumonia |
Q52625631 | Clinical and epidemiological characterization of influenza virus infections in children with severe acute respiratory infection in Maputo, Mozambique: Results from the implementation of sentinel surveillance, 2014 - 2016. |
Q37546216 | Clinical and virologic factors associated with reduced sensitivity of rapid influenza diagnostic tests in hospitalized elderly patients and young children. |
Q30353609 | Clinical care for severe influenza and other severe illness in resource-limited settings: the need for evidence and guidelines. |
Q37638413 | Clinical characteristics and factors associated with severe acute respiratory infection and influenza among children in Jingzhou, China |
Q60915570 | Clinical characteristics and viral etiologies of outpatients with acute respiratory infections in Huzhou of China: a retrospective study |
Q58698988 | Coinfection With Influenza A Virus and : An Underrecognized Impact on Host Resistance and Tolerance to Pulmonary Infections |
Q59350851 | Combination of procalcitonin and C-reactive protein levels in the early diagnosis of bacterial co-infections in children with H1N1 influenza |
Q30420603 | Comparative study of influenza virus replication in MDCK cells and in primary cells derived from adenoids and airway epithelium |
Q59353232 | Comparison of Six Sample-to-Answer Influenza A/B and Respiratory Syncytial Virus Nucleic Acid Amplification Assays Using Respiratory Specimens from Children |
Q34183807 | Comparison of a new transport medium with universal transport medium at a tropical field site |
Q34872526 | Comparison of different risk perception measures in predicting seasonal influenza vaccination among healthy Chinese adults in Hong Kong: a prospective longitudinal study. |
Q54088460 | Comparison of incidence and cost of influenza between healthy and high-risk children <60 months old in Thailand, 2011-2015. |
Q92667355 | Comparison of the ID Now Influenza A & B 2, Cobas Influenza A/B, and Xpert Xpress Flu Point-of-Care Nucleic Acid Amplification Tests for Influenza A/B Virus Detection in Children |
Q92030457 | Comparison of the detection performance of two different one-step-combined test strips with fluorescent microspheres or colored microspheres as tracers for influenza A and B viruses |
Q64129672 | Comparison of the new fully automated extraction platform eMAG to the MagNA PURE 96 and the well-established easyMAG for detection of common human respiratory viruses |
Q49728845 | Comparison of the prevalence of respiratory viruses in patients with acute respiratory infections at different hospital settings in North China, 2012-2015. |
Q36465927 | Complete Genome Sequence of Human Respiratory Syncytial Virus Isolated in Mexico |
Q58601863 | Complexities and dilemmas in community consultation on the design of a research project logo in Malawi |
Q26796324 | Considerations of strategies to provide influenza vaccine year round |
Q50062763 | Construction of a Transcriptome-Driven Network at the Early Stage of Infection with Influenza A H1N1 in Human Lung Alveolar Epithelial Cells |
Q37331059 | Contribution of influenza viruses to medically attended acute respiratory illnesses in children in high-income countries: a meta-analysis |
Q38702032 | Coptidis Rhizoma extract inhibits replication of respiratory syncytial virus in vitro and in vivo by inducing antiviral state. |
Q45839781 | Cord blood 25(OH)D levels and the subsequent risk of lower respiratory tract infections in early childhood: the Ulm birth cohort |
Q89959899 | Cost-effectiveness of inactivated influenza vaccination in children with medical risk conditions in the Netherlands |
Q29247948 | Cost-effectiveness of maternal influenza immunization in Bamako, Mali: A decision analysis |
Q37194981 | DNA Vaccines Encoding Antigen Targeted to MHC Class II Induce Influenza-Specific CD8(+) T Cell Responses, Enabling Faster Resolution of Influenza Disease |
Q35008712 | Deconstructing the differences: a comparison of GBD 2010 and CHERG's approach to estimating the mortality burden of diarrhea, pneumonia, and their etiologies. |
Q35885039 | Delivery of subunit influenza vaccine to skin with microneedles improves immunogenicity and long-lived protection |
Q38675782 | Demographic and ecological risk factors for human influenza A virus infections in rural Indonesia |
Q39264479 | Demographic, socio-economic and geographic determinants of seasonal influenza vaccine uptake in rural western Kenya, 2011. |
Q92219746 | Dengue Virus and Influenza A Virus Co-Infection in Pregnancy: A Case Report |
Q54235918 | Descriptive study of severe hospitalized cases of laboratory-confirmed influenza during five epidemic seasons (2010-2015). |
Q91652344 | Determinants of Fatal Outcome in Patients Admitted to Intensive Care Units With Influenza, European Union 2009-2017 |
Q30364045 | Determinants of receiving the pandemic (H1N1) 2009 vaccine and intention to receive the seasonal influenza vaccine in Taiwan. |
Q35685999 | Determining the Provincial and National Burden of Influenza-Associated Severe Acute Respiratory Illness in South Africa Using a Rapid Assessment Methodology |
Q40728418 | Diagnostic performance of influenza viruses and RSV rapid antigen detection tests in children in tertiary care |
Q36302217 | Disease burden of 2013-2014 seasonal influenza in adults in Korea. |
Q55220726 | Distribution of influenza virus types by age using case-based global surveillance data from twenty-nine countries, 1999-2014. |
Q28073431 | Do antibody responses to the influenza vaccine persist year-round in the elderly? A systematic review and meta-analysis |
Q34551229 | Do children with uncomplicated severe acute malnutrition need antibiotics? A systematic review and meta-analysis. |
Q53283393 | Does consecutive influenza vaccination reduce protection against influenza: A systematic review and meta-analysis |
Q38230208 | Does vitamin D protect against respiratory viral infections? |
Q30234600 | Drug resistance in influenza A virus: the epidemiology and management |
Q59358581 | EMAPII Monoclonal Antibody Ameliorates Influenza A Virus-Induced Lung Injury |
Q91627985 | Early Induction of Cross-Reactive CD8+ T-Cell Responses in Tonsils After Live-Attenuated Influenza Vaccination in Children |
Q90347827 | Economic Cost of Severe Acute Respiratory Infection Associated to Influenza in Colombian Children: A Single Setting Analysis |
Q30396485 | Effect of Influenza Vaccination of Children on Infection Rate in Hutterite Communities: Follow-Up Study of a Randomized Trial |
Q33699031 | Effect of early measles vaccine on pneumococcal colonization: A randomized trial from Guinea-Bissau |
Q28077038 | Effectiveness of influenza vaccination for preventing influenza-related complications in people with asthma: a systematic review protocol |
Q39358078 | Effectiveness of influenza vaccines in asthma: a systematic review and meta-analysis |
Q42215844 | Effectiveness of neuraminidase inhibitors for severe influenza |
Q36870297 | Effectiveness of seasonal influenza vaccines in children -- a systematic review and meta-analysis |
Q36232932 | Effectiveness of seasonal trivalent inactivated influenza vaccine in preventing influenza hospitalisations and primary care visits in Auckland, New Zealand, in 2013 |
Q39680416 | Effectiveness of the 2013 and 2014 Southern Hemisphere Influenza Vaccines Against Laboratory-confirmed Influenza in Young Children Using a Test-negative Design, Bangkok, Thailand |
Q30419503 | Effectiveness of the monovalent AS03-adjuvanted influenza A(H1N1)pdm09 vaccine against hospitalization in children because of influenza |
Q30353405 | Efficacy and effectiveness of seasonal and pandemic A (H1N1) 2009 influenza vaccines in low and middle income countries: a systematic review and meta-analysis. |
Q37427256 | Efficacy of a Russian-backbone live attenuated influenza vaccine among children in Senegal: a randomised, double-blind, placebo-controlled trial |
Q30829284 | Efficacy of a Russian-backbone live attenuated influenza vaccine among young children in Bangladesh: a randomised, double-blind, placebo-controlled trial |
Q92758287 | Efficacy of inactivated trivalent influenza vaccine in rural India: a 3-year cluster-randomised controlled trial |
Q40152886 | Efficacy of oseltamivir treatment started within 5 days of symptom onset to reduce influenza illness duration and virus shedding in an urban setting in Bangladesh: a randomised placebo-controlled trial |
Q47100142 | Efficacy of trivalent influenza vaccine against laboratory-confirmed influenza among young children in a randomized trial in Bangladesh |
Q52598059 | Efficacy, immunogenicity, and safety evaluation of an MF59-adjuvanted quadrivalent influenza virus vaccine compared with non-adjuvanted influenza vaccine in children: a multicentre, randomised controlled, observer-blinded, phase 3 trial |
Q54263126 | Endogenous Cellular MicroRNAs Mediate Antiviral Defense against Influenza A Virus |
Q39308116 | Enhanced and persistent antibody response against homologous and heterologous strains elicited by a MF59-adjuvanted influenza vaccine in infants and young children |
Q28544035 | Epidemiological and virological characteristics of influenza viruses circulating in Cambodia from 2009 to 2011 |
Q57490857 | Epidemiology and Immune Pathogenesis of Viral Sepsis |
Q64075268 | Epidemiology and burden of influenza in healthy children aged 6 to 35 months: analysis of data from the placebo arm of a phase III efficacy trial |
Q57177037 | Epidemiology and clinical characteristics of acute respiratory tract infections among hospitalized infants and young children in Chengdu, West China, 2009-2014 |
Q36978069 | Epidemiology and etiology of childhood pneumonia in 2010: estimates of incidence, severe morbidity, mortality, underlying risk factors and causative pathogens for 192 countries |
Q47551340 | Epidemiology and molecular characterization of influenza viruses in Burkina Faso, sub-Saharan Africa |
Q39625249 | Epidemiology characteristics of respiratory viruses found in children and adults with respiratory tract infections in southern China |
Q59126599 | Epidemiology of circulating human influenza viruses from the Democratic Republic of Congo, 2015 |
Q28269717 | Estimated global mortality associated with the first 12 months of 2009 pandemic influenza A H1N1 virus circulation: a modelling study |
Q36316486 | Estimated incidence of influenza-virus-associated severe pneumonia in children in El Salvador, 2008-2010. |
Q46876629 | Estimates of global seasonal influenza-associated respiratory mortality: a modelling study |
Q90544416 | Estimating Influenza-associated Mortality in Korea: The 2009-2016 Seasons |
Q47578173 | Estimating burden of influenza-associated influenza-like illness and severe acute respiratory infection at public healthcare facilities in Romania during the 2011/12-2015/16 influenza seasons. |
Q33884440 | Estimating influenza and respiratory syncytial virus-associated mortality in Western Kenya using health and demographic surveillance system data, 2007-2013 |
Q34292657 | Estimating influenza outpatients' and inpatients' incidences from 2009 to 2011 in a tropical urban setting in the Philippines |
Q35108244 | Estimating oxygen needs for childhood pneumonia in developing country health systems: a new model for expecting the unexpected |
Q55426279 | Estimating the Risk of Influenza-Like Illness Transmission Through Social Contacts: Web-Based Participatory Cohort Study. |
Q54223716 | Estimating the annual attack rate of seasonal influenza among unvaccinated individuals: A systematic review and meta-analysis. |
Q46586814 | Estimating the burden of influenza-associated hospitalization and deaths in Oman (2012-2015). |
Q37010806 | Estimating the burden of influenza-associated hospitalizations and deaths in Central America |
Q49989809 | Estimating the burden of influenza-associated hospitalizations and deaths in Chile during 2012-2014. |
Q47640103 | Estimation of Burden of Influenza among under-Five Children in India: A Meta-Analysis |
Q52561206 | Estimation of community-level influenza-associated illness in a low resource rural setting in India. |
Q92801965 | Estimation of influenza and respiratory syncytial virus hospitalizations using sentinel surveillance data-La Paz, Bolivia. 2012-2017 |
Q59353019 | Estimation of the burden of flu-association influenza-like illness visits on total clinic visits through the sentinel influenza monitoring system in Senegal during the 2013-2015 influenza seasons |
Q34661599 | Estimation of the national disease burden of influenza-associated severe acute respiratory illness in Kenya and Guatemala: a novel methodology |
Q33968181 | Ethics and Community Involvement in Syntheses Concerning American Indian, Alaska Native, or Native Hawaiian Health: A Systematic Review |
Q35876176 | Etiology and Factors Associated with Pneumonia in Children under 5 Years of Age in Mali: A Prospective Case-Control Study |
Q36323004 | Etiology and seasonality of viral respiratory infections in rural Honduran children |
Q64375713 | Etiology of acute viral respiratory infections common in Pakistan: A review |
Q36275637 | Etiology of severe pneumonia in Ecuadorian children |
Q37681302 | Evaluating the effectiveness, impact and safety of live attenuated and seasonal inactivated influenza vaccination: protocol for the Seasonal Influenza Vaccination Effectiveness II (SIVE II) study. |
Q64257540 | Evaluation of Mannose Binding Lectin Gene Variants in Pediatric Influenza Virus-Related Critical Illness |
Q64064386 | Evaluation of a phased pneumococcal conjugate vaccine introduction in Mongolia using enhanced pneumonia surveillance and community carriage surveys: a study protocol for a prospective observational study and lessons learned |
Q36299475 | Evaluation of case definitions for estimation of respiratory syncytial virus associated hospitalizations among children in a rural community of northern India |
Q30360215 | Evidence compendium and advice on social distancing and other related measures for response to an influenza pandemic. |
Q91786395 | Examining the Complex Relationship Between Tuberculosis and Other Infectious Diseases in Children |
Q47130609 | Excess pneumonia and influenza mortality attributable to seasonal influenza in subtropical Shanghai, China. |
Q24187621 | Exercise prior to influenza vaccination for limiting influenza incidence and its related complications in adults |
Q30248365 | Exercise prior to influenza vaccination for limiting influenza incidence and its related complications in adults. |
Q30385120 | Extensive multiplex PCR diagnostics reveal new insights into the epidemiology of viral respiratory infections. |
Q37669436 | Fifteen years of epidemiologic, virologic and syndromic influenza surveillance: A focus on type B virus and the effects of vaccine mismatch in Liguria region, Italy. |
Q38534169 | Fluarix quadrivalent vaccine for influenza |
Q39617343 | Frequent Isolations of Influenza A Viruses (H1N1)pdm09 with Identical Hemagglutinin Sequences for More Than Three Months in Japan |
Q64239457 | Genetic and antigenic characterisation of influenza A(H3N2) viruses isolated in Yokohama during the 2016/17 and 2017/18 influenza seasons |
Q47100436 | Genetic and antigenic divergence in the influenza A(H3N2) virus circulating between 2016 and 2017 in Thailand |
Q39680868 | Genetic characterization of human bocavirus among children with severe acute respiratory infection in China |
Q40131850 | Genotyping assay for differentiation of wild-type and vaccine viruses in subjects immunized with live attenuated influenza vaccine |
Q26751854 | Global Role and Burden of Influenza in Pediatric Respiratory Hospitalizations, 1982–2012: A Systematic Analysis |
Q37702426 | Global and regional burden of hospital admissions for severe acute lower respiratory infections in young children in 2010: a systematic analysis |
Q28288886 | Global burden of childhood pneumonia and diarrhoea |
Q30371604 | Global burden of influenza as a cause of cardiopulmonary morbidity and mortality |
Q89842863 | Global burden of respiratory infections associated with seasonal influenza in children under 5 years in 2018: a systematic review and modelling study |
Q26782024 | Global, regional, and national age-sex specific all-cause and cause-specific mortality for 240 causes of death, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013. |
Q38687853 | Global, regional, and national disease burden estimates of acute lower respiratory infections due to respiratory syncytial virus in young children in 2015: a systematic review and modelling study |
Q91774677 | Health outcomes of young children born to mothers who received 2009 pandemic H1N1 influenza vaccination during pregnancy: retrospective cohort study |
Q40427971 | Hemagglutination inhibiting antibody persistence 1 year after influenza vaccination in Korean children and adolescents. |
Q28066385 | Herd effect from influenza vaccination in non-healthcare settings: a systematic review of randomised controlled trials and observational studies |
Q36271660 | High pneumonia lifetime-ever incidence in Beijing children compared with locations in other countries, and implications for national PCV and Hib vaccination |
Q40097305 | Histone Deacetylase 2 Is a Component of Influenza A Virus-Induced Host Antiviral Response |
Q47182639 | History and current trends in influenza virus infections with special reference to Sri Lanka |
Q93192117 | Hospitalization and death among patients with influenza, Guatemala, 2008-2012 |
Q34781034 | Hospitalizations associated with influenza and respiratory syncytial virus among patients attending a network of private hospitals in South Africa, 2007-2012. |
Q100385691 | Host Retromer Protein Sorting Nexin 2 Interacts with Human Respiratory Syncytial Virus Structural Proteins and is Required for Efficient Viral Production |
Q43169598 | Household-level risk factors for influenza among young children in Dhaka, Bangladesh: a case-control study |
Q47233468 | How close are countries of the WHO European Region to achieving the goal of vaccinating 75% of key risk groups against influenza? Results from national surveys on seasonal influenza vaccination programmes, 2008/2009 to 2014/2015. |
Q93158881 | How long are children protected by influenza vaccination? |
Q35496504 | Identification of children at risk of influenza-related complications in primary and ambulatory care: a systematic review and meta-analysis |
Q36851155 | Immunogenicity and Safety of 2 Dose Levels of a Thimerosal-Free Trivalent Seasonal Influenza Vaccine in Children Aged 6-35 Months: A Randomized, Controlled Trial |
Q57466752 | Immunogenicity and safety of MF59-adjuvanted and full-dose unadjuvanted trivalent inactivated influenza vaccines among vaccine-naïve children in a randomized clinical trial in rural Senegal |
Q92158515 | Immunogenicity and safety of Quadrivalent Influenza HA vaccine in Indonesian children: An open-labeled, bridging, clinical study |
Q52650190 | Immunogenicity and safety of a Trivalent Influenza HA vaccine in Indonesian infants and children |
Q59354505 | Impact of Cigarette Smoke Exposure on the Lung Fibroblastic Response after Influenza Pneumonia |
Q35661251 | Impact of Intensive Handwashing Promotion on Secondary Household Influenza-Like Illness in Rural Bangladesh: Findings from a Randomized Controlled Trial |
Q91466173 | Impact of a quadrivalent inactivated influenza vaccine on influenza-associated complications and health care use in children aged 6 to 35 months: Analysis of data from a phase III trial in the Northern and Southern Hemispheres |
Q90128042 | Impact of funding influenza vaccination on coverage among Australian children: a national study using MedicineInsight, a large general practice database |
Q39638371 | Impact of oseltamivir use on the reduction of complications in patients with influenza: a prospective study |
Q35884777 | Improving influenza surveillance in sub-Saharan Africa. |
Q57094109 | Improving preparedness for the next flu pandemic |
Q33686093 | Inaccurate ascertainment of morbidity and mortality due to influenza in administrative databases: a population-based record linkage study |
Q89947480 | Incidence of Influenza Among Childhood Cancer Survivors in South Korea: A Population-based Retrospective Analysis |
Q40052471 | Incidence of laboratory-confirmed influenza disease among infants under 6 months of age: a systematic review |
Q28587444 | Incidence of medically attended influenza among residents of Shai-Osudoku and Ningo-Prampram Districts, Ghana, May 2013 - April 2015 |
Q41053454 | Incidence of medically attended influenza infection and cases averted by vaccination, 2011/2012 and 2012/2013 influenza seasons |
Q35819735 | Incidence of viral respiratory infections in a prospective cohort of outpatient and hospitalized children aged ≤5 years and its associated cost in Buenos Aires, Argentina |
Q59355642 | Increased severity of respiratory syncytial virus airway infection due to passive smoke exposure |
Q60912736 | Indirect protection from vaccinating children against influenza in households |
Q27021304 | Induction of protective effector immunity to prevent pathogenesis caused by the respiratory syncytial virus. Implications on therapy and vaccine design |
Q37616332 | Infants and the seasonal influenza vaccine. A global perspective on safety, effectiveness, and alternate forms of protection |
Q52731949 | Inflammatory Monocytes Drive Influenza A Virus-Mediated Lung Injury in Juvenile Mice. |
Q37058954 | Influence of bacterial interactions on pneumococcal colonization of the nasopharynx |
Q26799729 | Influenza A Virus Infection, Innate Immunity, and Childhood |
Q92730961 | Influenza A and B in a cohort of outpatient children and adolescent with influenza like-illness during two consecutive influenza seasons |
Q35934042 | Influenza A and Parvovirus B19 Seropositivity Rates in Gabonese Infants |
Q47613880 | Influenza Among Young Children in Bangladesh: Clinical Characteristics and Outcomes From a Randomized Clinical Trial. |
Q28085254 | Influenza Burden and Transmission in the Tropics |
Q92652747 | Influenza Vaccination: Effectiveness, Indications, and Limits in the Pediatric Population |
Q37568360 | Influenza Vaccine Effectiveness for Fully and Partially Vaccinated Children 6 Months to 8 Years Old During 2011-2012 and 2012-2013: The Importance of Two Priming Doses |
Q64251661 | Influenza Virus Infections and Cellular Kinases |
Q37101395 | Influenza activity in Kenya, 2007-2013: timing, association with climatic factors, and implications for vaccination campaigns |
Q38068065 | Influenza and respiratory syncytial virus (RSV) vaccines for infants: Safety, immunogenicity, and efficacy |
Q29248088 | Influenza and respiratory syncytial virus in infants study (IRIS) of hospitalized and non-ill infants aged <1 year in four countries: study design and methods |
Q90376830 | Influenza and tuberculosis co-infection: A systematic review |
Q42548938 | Influenza at the beginning of the 21st century |
Q30387836 | Influenza epidemiology among hospitalized children in Stockholm, Sweden 1998-2014. |
Q40059792 | Influenza epidemiology and immunization during pregnancy: Final report of a World Health Organization working group |
Q98893471 | Influenza epidemiology and risk factors for severe acute respiratory infection in Morocco during the 2016/2017 and 2017/2018 seasons |
Q93038069 | Influenza in Latin America: A report from the Global Influenza Initiative (GII) |
Q30423845 | Influenza surveillance in 15 countries in Africa, 2006-2010. |
Q27321447 | Influenza vaccination accelerates recovery of ferrets from lymphopenia |
Q37450549 | Influenza vaccination among household contacts of children with cystic fibrosis and healthy children |
Q30354181 | Influenza vaccination in India: position paper of Indian Academy of Pediatrics, 2013. |
Q38798316 | Influenza vaccine effectiveness among high-risk groups: A systematic literature review and meta-analysis of case-control and cohort studies |
Q40191494 | Influenza vaccine effectiveness for hospital and community patients using control groups with and without non-influenza respiratory viruses detected, Auckland, New Zealand 2014 |
Q35085391 | Influenza vaccines and influenza antiviral drugs in Africa: are they available and do guidelines for their use exist? |
Q101403095 | Influenza virus infection augments susceptibility to respiratory Yersinia pestis exposure and impacts the efficacy of antiplague antibiotic treatments |
Q26781841 | Influenza-Associated Disease Burden in Kenya: A Systematic Review of Literature |
Q36048988 | Influenza-associated outpatient visits among children less than 5 years of age in eastern China, 2011-2014. |
Q91886595 | Influenza-associated pneumonia hospitalizations in Uganda, 2013-2016 |
Q35956545 | Influenza-like illness in an urban community of Salvador, Brazil: incidence, seasonality and risk factors |
Q30418373 | Influenza: Options to Improve Pandemic Preparation |
Q28596741 | Influenza: from zoonosis to pandemic |
Q94587786 | Intent to obtain pediatric influenza vaccine among mothers in four middle income countries |
Q42696030 | International meeting on influenza vaccine effectiveness, 3-4 December 2012, Geneva, Switzerland |
Q38204774 | Key issues and challenges in estimating the impact and cost-effectiveness of quadrivalent influenza vaccination |
Q33613533 | Knowledge, attitudes and behaviour of hospital health-care workers regarding influenza A/H1N1: a cross sectional survey. |
Q94361023 | Les avantages d’administrer le vaccin antigrippal pendant la grossesse pour le fœtus et le nourrisson de moins de six mois |
Q55618024 | Les avantages d’administrer le vaccin antigrippal pendant la grossesse pourle fœtus et le nourrisson de moins de six mois. |
Q40100307 | Literature review on human influenza epidemics occurred before the implementation plan for sentinel surveillance program in the DRC |
Q50071104 | Live Attenuated Influenza Vaccination Prior To Age 3 Years and Subsequent Development of Asthma: A 14-Year Follow-Up Study |
Q38416489 | Live attenuated influenza vaccine tetravalent: a clinical review |
Q58811343 | Long-term effects of pneumonia in young children |
Q58811345 | Long-term effects of pneumonia in young children |
Q26740162 | Lung epithelial GM-CSF improves host defense function and epithelial repair in influenza virus pneumonia-a new therapeutic strategy? |
Q26783493 | M2e-Based Universal Influenza A Vaccines |
Q61453230 | Maternal Influenza Vaccination and the Risk of Laboratory-Confirmed Influenza Among Household Contacts Under the Age of Five in Mali |
Q37176794 | Maternal immunisation with trivalent inactivated influenza vaccine for prevention of influenza in infants in Mali: a prospective, active-controlled, observer-blind, randomised phase 4 trial |
Q40195938 | Maternal influenza immunisation to reduce influenza infections and low birthweight in infants in resource-limited countries |
Q47239279 | Maternal influenza vaccine strategies in Kenya: Which approach would have the greatest impact on disease burden in pregnant women and young infants? |
Q30386781 | Maternal vaccination for the prevention of influenza: current status and hopes for the future. |
Q27022693 | Modulation of host adaptive immunity by hRSV proteins |
Q49886937 | Monoclonal antibody based in vitro potency assay as a predictor of antigenic integrity and in vivo immunogenicity of a Respiratory Syncytial Virus post-fusion F-protein based vaccine |
Q36126614 | Morbidity, Mortality, and Seasonality of Influenza Hospitalizations in Egypt, November 2007-November 2014 |
Q30359417 | Mortality associated with seasonal and pandemic influenza and respiratory syncytial virus among children <5 years of age in a high HIV prevalence setting--South Africa, 1998-2009. |
Q42236082 | Mortality in Cambodia: an 18-month prospective community-based surveillance of all-age deaths using verbal autopsies |
Q92978914 | Mortality risk factors in children with severe influenza virus infection admitted to the pediatric intensive care unit |
Q36651364 | Neonatal pneumococcal colonisation caused by Influenza A infection alters lung function in adult mice |
Q91779617 | Neonatal vaccine effectiveness and the role of adjuvants |
Q30418570 | Novel Viral Vectored Vaccines for the Prevention of Influenza |
Q92503610 | Novel correlates of protection against pandemic H1N1 influenza A virus infection |
Q42239583 | Optimum timing of oseltamivir: lessons from Bangladesh |
Q92916882 | Oral influenza vaccination-a possible solution for the next pandemic? |
Q47662382 | Oseltamivir Treatment of Influenza in Children. |
Q64897863 | Outbreak detection of influenza-like illness in Prey Veng Province, Cambodia: a community-based surveillance. |
Q30432173 | Overview of influenza virus infections in Kenya: past, present and future |
Q53669070 | Paediatric influenza vaccination: time to better protect high-risk groups? |
Q41617661 | Pan-human coronavirus and human bocavirus SYBR Green and TaqMan PCR assays; use in studying influenza A viruses co-infection and risk of hospitalization |
Q55640741 | Pandemic Flu, 1918: After hundred years, India is as vulnerable. |
Q30424269 | Pandemic H1N1 influenza surveillance in Haiti, July–December 2009 |
Q30351881 | Pandemic influenza A(H1N1)pdm09: an unrecognized cause of mortality in children in Pakistan |
Q43167569 | Parental perceptions of childhood seasonal influenza vaccination in Singapore: A cross-sectional survey. |
Q38575199 | Path to impact: A report from the Bill and Melinda Gates Foundation convening on maternal immunization in resource-limited settings; Berlin - January 29-30, 2015. |
Q33910984 | Pediatricians' perceptions of vaccine effectiveness and safety are significant predictors of vaccine administration in India. |
Q91782516 | Peptide Antiviral Strategies as an Alternative to Treat Lower Respiratory Viral Infections |
Q27336918 | Peripheral Leukocyte Migration in Ferrets in Response to Infection with Seasonal Influenza Virus |
Q39132734 | Pilot study to harmonize the reported influenza intensity levels within the Spanish Influenza Sentinel Surveillance System (SISSS) using the Moving Epidemic Method (MEM). |
Q35108485 | Population-based incidence of severe acute respiratory virus infections among children aged <5 years in rural Bangladesh, June-October 2010 |
Q47151103 | Possible interference between seasonal epidemics of influenza and other respiratory viruses in Hong Kong, 2014-2017. |
Q23909568 | Potential impact of co-infections and co-morbidities prevalent in Africa on influenza severity and frequency: a systematic review |
Q54215595 | Potential impact of influenza vaccine roll-out on antibiotic use in Africa |
Q93160140 | Potential underestimation of influenza virus burden in infants |
Q30398711 | Predictors of influenza a molecular viral shedding in Hutterite communities. |
Q36458000 | Prevalence of Acute Lower Respiratory Tract Infections due to Respiratory Syncytial Virus in Amirkola Children's hospital, Northern Iran during March 2008-March 2010 |
Q49587453 | Prevention of influenza-related illness in young infants by maternal vaccination during pregnancy |
Q91311604 | Priming with MF59 adjuvanted versus nonadjuvanted seasonal influenza vaccines in children - A systematic review and a meta-analysis |
Q63866060 | Prioritization of risk groups for influenza vaccination in resource limited settings - A case study from South Africa |
Q56944974 | Progress and Remaining Gaps in Estimating the Global Disease Burden of Influenza |
Q39912152 | Psychosocial Influences on Parental Decision-Making Regarding Vaccination Against Seasonal Influenza for Young Children in Hong Kong: a Longitudinal Study, 2012-2013. |
Q61803450 | Public Health-Driven Research and Innovation for Next-Generation Influenza Vaccines, European Union |
Q35618994 | Public health impact and cost-effectiveness of intranasal live attenuated influenza vaccination of children in Germany |
Q38148075 | Quality of life for parents of children with influenza-like illness: development and validation of Care-ILI-QoL. |
Q39447550 | Randomized safety and immunogenicity trial of a seasonal trivalent inactivated split virion influenza vaccine (IVACFLU-S) in healthy young Vietnamese adults |
Q40286902 | Rapid Influenza Diagnostic Tests Improve Suitability of Antiviral Treatment in Hospitalized Children |
Q40227231 | Rates of respiratory virus-associated hospitalization in children aged <5 years in rural northern India |
Q63246353 | Recent Updates on Mouse Models for Human Immunodeficiency, Influenza, and Dengue Viral Infections |
Q36978046 | Reducing mortality from childhood pneumonia and diarrhoea: The leading priority is also the greatest opportunity |
Q39695257 | Reduction in emergency department visits for children's asthma, ear infections, and respiratory infections after the introduction of state smoke-free legislation. |
Q30421294 | Report of the 5th meeting on influenza vaccines that induce broad spectrum and long-lasting immune responses, World Health Organization, Geneva, 16–17 November 2011 |
Q47340934 | Report on eighth WHO meeting on development of influenza vaccines that induce broadly protective and long-lasting immune responses: Chicago, USA, 23-24 August 2016. |
Q50950154 | Report on the second WHO integrated meeting on development and clinical trials of influenza vaccines that induce broadly protective and long-lasting immune responses: Geneva, Switzerland, 5-7 May 2014. |
Q64378983 | Respiratory Viral Infections in Pediatric Solid Organ and Hematopoietic Stem Cell Transplantation |
Q47150385 | Respiratory syncytial and influenza viruses in children under 2 years old with severe acute respiratory infection (SARI) in Maputo, 2015. |
Q91861087 | Respiratory syncytial virus contributes to more severe respiratory morbidity than influenza in children < 2 years during seasonal influenza peaks |
Q35102554 | Respiratory syncytial virus transplacental antibody transfer and kinetics in mother-infant pairs in Bangladesh |
Q35761061 | Respiratory syncytial virus, an ongoing medical dilemma: an expert commentary on respiratory syncytial virus prophylactic and therapeutic pharmaceuticals currently in clinical trials |
Q37357816 | Respiratory virus surveillance in hospitalised pneumonia patients on the Thailand-Myanmar border |
Q90747724 | Respiratory virus-induced heterologous immunity: Part of the problem or part of the solution? |
Q92000490 | Respiratory virus-induced heterologous immunity: Part of the problem or part of the solution? |
Q33794206 | Results from the first six years of national sentinel surveillance for influenza in Kenya, July 2007-June 2013 |
Q28077335 | Reviewing the History of Pandemic Influenza: Understanding Patterns of Emergence and Transmission |
Q92827733 | Role for maternal asthma in severe human metapneumovirus lung disease susceptibility in children |
Q38036585 | Role of Viruses in the Development of Atopic Disease in Pediatric Patients |
Q36009663 | Safety and Immunogenicity of Full-Dose Trivalent Inactivated Influenza Vaccine (TIV) Compared With Half-Dose TIV Administered to Children 6 Through 35 Months of Age. |
Q43625547 | Safety and immunogenicity of a Sf9 insect cell-derived respiratory syncytial virus fusion protein nanoparticle vaccine |
Q47193444 | Safety and immunogenicity of a seasonal trivalent inactivated split influenza vaccine: a phase I randomized clinical trial in healthy Serbian adults |
Q40275964 | Safety of Russian-backbone seasonal trivalent, live-attenuated influenza vaccine in a phase II randomized placebo-controlled clinical trial among children in urban Bangladesh |
Q30369101 | Seasonal and pandemic influenza vaccine: Demand, supply and vaccine availability |
Q34445842 | Seasonal influenza immunization in early infancy? |
Q40740131 | Seasonal influenza vaccine effectiveness against medically attended influenza illness among children aged 6-59 months, October 2011-September 2012: A matched test-negative case-control study in Suzhou, China |
Q26769664 | Seasonal influenza vaccine policy, use and effectiveness in the tropics and subtropics - a systematic literature review |
Q39303034 | Sentinel Surveillance for Influenza in Senegal, 1996–2009 |
Q36358893 | Setting priorities for development of emerging interventions against childhood pneumonia, meningitis and influenza |
Q36784739 | Severe Acute Respiratory Illness Deaths in Sub-Saharan Africa and the Role of Influenza: A Case Series From 8 Countries |
Q46453926 | Severe Acute Respiratory Illness in Sub-Saharan Africa |
Q35154420 | Severe acute respiratory infection in children in a densely populated urban slum in Kenya, 2007-2011. |
Q39454744 | Severe influenza in children: incidence and risk factors |
Q37335166 | Severe influenza-associated respiratory infection in high HIV prevalence setting, South Africa, 2009-2011. |
Q55008944 | Severe outcomes associated with respiratory viruses in newborns and infants: a prospective viral surveillance study in Jordan. |
Q40419642 | Severity of Respiratory Syncytial Virus Lower Respiratory Tract Infection With Viral Coinfection in HIV-Uninfected Children |
Q42235311 | Single, dual and multiple respiratory virus infections and risk of hospitalization and mortality. |
Q30204000 | Southern Hemisphere Influenza and Vaccine Effectiveness Research and Surveillance |
Q91529544 | Structural basis for influenza virus NS1 protein block of mRNA nuclear export |
Q28602586 | Supplementation of H1N1pdm09 split vaccine with heterologous tandem repeat M2e5x virus-like particles confers improved cross-protection in ferrets |
Q89790236 | Suppression of Cytotoxic T Cell Functions and Decreased Levels of Tissue Resident Memory T cell During H5N1 infection |
Q90395754 | Surveillance Data for Eight Consecutive Influenza Seasons in Sicily, Italy |
Q46594711 | Surveillance for respiratory infections in low- and middle-income countries: experience from the Centers for Disease Control and Prevention's Global Disease Detection International Emerging Infections Program |
Q35007304 | TLR3 signaling in macrophages is indispensable for the protective immunity of invariant natural killer T cells against enterovirus 71 infection |
Q55375628 | TRPM8 and RAAS-mediated hypertension is critical for cold-induced immunosuppression in mice. |
Q30365791 | Technology transfer and scale-up of the Flublok recombinant hemagglutinin (HA) influenza vaccine manufacturing process. |
Q35974951 | Temporal Patterns of Influenza A and B in Tropical and Temperate Countries: What Are the Lessons for Influenza Vaccination? |
Q35712481 | Ten year retrospective evaluation of the seasonal distribution of agent viruses in childhood respiratory tract infections |
Q33747338 | The Antibody-Secreting Cell Response to Infection: Kinetics and Clinical Applications |
Q52367800 | The Burden of Influenza: a Complex Problem. |
Q55101403 | The CD8 T Cell Response to Respiratory Virus Infections. |
Q35614461 | The East Jakarta Project: surveillance for highly pathogenic avian influenza A(H5N1) and seasonal influenza viruses in patients seeking care for respiratory disease, Jakarta, Indonesia, October 2011-September 2012. |
Q64077362 | The Impact of Influenza and Tuberculosis Interaction on Mortality Among Individuals Aged ≥15 Years Hospitalized With Severe Respiratory Illness in South Africa, 2010-2016 |
Q28607616 | The Nicaraguan pediatric influenza cohort study: design, methods, use of technology, and compliance |
Q90745138 | The Role of Clinical Virology Laboratory and the Clinical Virology Laboratorian in Ensuring Effective Surveillance for Influenza and Other Respiratory Viruses: Points to Consider and Pitfalls to Avoid |
Q30379227 | The Unrecognized Burden of Influenza in Young Kenyan Children, 2008-2012 |
Q94361019 | The benefits of influenza vaccine in pregnancy for the fetus and the infant younger than six months of age |
Q34531879 | The benefits of influenza vaccine in pregnancy for the fetus and the infant younger than six months of age. |
Q30208974 | The burden of influenza and RSV among inpatients and outpatients in rural western Kenya, 2009-2012 |
Q30430303 | The burden of seasonal and pandemic influenza in infants and children |
Q89842866 | The burden of viral respiratory infections in young children in low-resource settings |
Q30544245 | The development of chronic cough in children following presentation to a tertiary paediatric emergency department with acute respiratory illness: study protocol for a prospective cohort study |
Q100517409 | The disease burden of influenza beyond respiratory illness |
Q36207731 | The effectiveness of seasonal trivalent inactivated influenza vaccine in preventing laboratory confirmed influenza hospitalisations in Auckland, New Zealand in 2012 |
Q47569006 | The effects of the attributable fraction and the duration of symptoms on burden estimates of influenza-associated respiratory illnesses in a high HIV prevalence setting, South Africa, 2013-2015. |
Q36055988 | The human side of influenza |
Q55447639 | The human viral challenge model: accelerating the evaluation of respiratory antivirals, vaccines and novel diagnostics. |
Q30432137 | The impact of influenza and respiratory syncytial virus on hospitalizations for lower respiratory tract infections in young children: Slovenia, 2006–2011 |
Q37011565 | The impact of influenza virus B in Italy: myth or reality? |
Q58760575 | The national and provincial burden of medically attended influenza-associated influenza-like illness and severe acute respiratory illness in the Democratic Republic of Congo, 2013-2015 |
Q46439181 | The national burden of influenza-associated severe acute respiratory illness hospitalization in Rwanda, 2012-2014. |
Q47192547 | The national burden of influenza-associated severe acute respiratory illness hospitalization in Zambia, 2011-2014. |
Q91751778 | The partnership for influenza vaccine introduction (PIVI): Supporting influenza vaccine program development in low and middle-income countries through public-private partnerships |
Q40933366 | The preventive effect of vaccine prophylaxis on severe respiratory syncytial virus infection: A meta-analysis. |
Q56567257 | The role of HIV in influenza- and respiratory syncytial virus-associated hospitalizations in South African children, 2011-2016 |
Q40841673 | The role of influenza, RSV and other common respiratory viruses in severe acute respiratory infections and influenza-like illness in a population with a high HIV sero-prevalence, South Africa 2012-2015. |
Q38048555 | The status of live viral vaccination in early life |
Q30355388 | The substantial hospitalization burden of influenza in central China: surveillance for severe, acute respiratory infection, and influenza viruses, 2010-2012. |
Q37035833 | Traditional and New Influenza Vaccines |
Q30421811 | Translating vaccine policy into action: a report from the Bill & Melinda Gates Foundation Consultation on the prevention of maternal and early infant influenza in resource-limited settings |
Q36950550 | Trivalent inactivated influenza vaccines induce broad immunological reactivity to both internal virion components and influenza surface proteins |
Q64447647 | Type I interferon induces CXCL13 to support ectopic germinal center formation |
Q93160134 | Underdetection of laboratory-confirmed influenza-associated hospital admissions among infants: a multicentre, prospective study |
Q30386388 | Universal influenza vaccines: Shifting to better vaccines. |
Q55344374 | Use of Multiple Imputation to Estimate the Proportion of Respiratory Virus Detections Among Patients Hospitalized With Community-Acquired Pneumonia. |
Q37130801 | Vaccines in pregnancy: The dual benefit for pregnant women and infants |
Q36155439 | Viral Specific Factors Contribute to Clinical Respiratory Syncytial Virus Disease Severity Differences in Infants |
Q35194072 | Viral aetiology of acute respiratory infections among children and associated meteorological factors in southern China |
Q33778766 | Viral etiologies of hospitalized acute lower respiratory infection patients in China, 2009-2013. |
Q64375170 | Viral pathogens associated with acute lower respiratory tract infections in children younger than 5 years of age in Bulgaria |
Q90269987 | Viruses associated with acute respiratory infection in a community-based cohort of healthy New Zealand children |
Q41918060 | WHO guide on the economic evaluation of influenza vaccination |
Q40799651 | Which influenza vaccine formulation should be used in Kenya? A comparison of influenza isolates from Kenya to vaccine strains, 2007-2013. |
Q59335660 | Whole Genome Sequencing of Influenza A and B Viruses With the MinION Sequencer in the Clinical Setting: A Pilot Study |
Q93344976 | [The universal influenza vaccination in children with Vaxigrip Tetra® in Italy: an evaluation of Health Technology Assessment] |
Search more.